NUTX Stock Risk & Deep Value Analysis
Nutex Health Inc
Healthcare • Medical Care Facilities
DVR Score
out of 10
What You Need to Know About NUTX Stock
We analyzed Nutex Health Inc using our deep value framework. Sign in to see our full verdict and DVR Score.
We ran NUTX through our deep value framework — analyzing financial health, distress signals, competitive moat, and risk factors. Our risk assessment: Aggressive. Here's what we found.
NUTX Risk Analysis & Red Flags
What Could Go Wrong
The company's primary revenue generation strategy, heavily reliant on arbitration practices, faces significant regulatory uncertainty from the No Surprises Act. An adverse ruling or stricter enforcement could severely diminish its revenue, lead to substantial losses, and necessitate highly dilutive capital raises to maintain operations.
Risk Matrix
Overall
Aggressive
Financial
High
Market
High
Competitive
High
Execution
Medium
Regulatory
High
Red Flags
- ⚠
Substantial Q4 2025 revenue and EPS miss against estimates.
- ⚠
Explicit and critical regulatory risk to arbitration revenue sustainability under No Surprises Act.
- ⚠
Unavailability of operating and free cash flow data for a capital-intensive business model.
- ⚠
High forward P/E (30.00) relative to trailing P/E (10.08-11.31) suggests expected future growth deceleration or earnings compression.
- ⚠
Potential future dilution from the $99.31M ESOP shelf.
Upcoming Risk Events
- 📅
Adverse regulatory rulings or unfavorable policy changes impacting arbitration revenue
- 📅
Further significant quarterly revenue and EPS misses
When to Reconsider
- 🚪
Quarterly revenue declines year-over-year or consecutive quarters of significant misses.
- 🚪
Reported operating or free cash flow turns significantly negative for two consecutive quarters.
- 🚪
Adverse regulatory rulings or legislative changes regarding arbitration practices that materially impact revenue.
Unlock NUTX Risk Analysis & Red Flags
Create a free account to see the full analysis
What Does Nutex Health Inc (NUTX) Do?
Market Cap
$618.94M
Sector
Healthcare
Industry
Medical Care Facilities
Employees
880
Nutex Health Inc. operates as a healthcare services and operations company in the United States. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The Hospital segment develops and operates a network of micro hospitals, specialty hospitals, and hospital outpatient departments that offer healthcare services, including emergency room care, inpatient care, and behavioural health. It also provides imaging services, such as CT scan, X-ray, MRI, ultrasound, etc.; laboratory services; and onsite inpatient pharmacies. The PHM segment provides management, administrative, and other support services to its affiliated hospitals and physician groups by establishing and operating provider networks, such as independent physician associations (IPAs); and a cloud-based technology platform for IPAs. The Real Estate segment owns and leases land and hospital buildings. The company was founded in 2011 and is headquartered in Houston, Texas.
Visit Nutex Health Inc WebsiteInvestment Thesis
Nutex Health has demonstrated significant top-line growth and achieved profitability, with a healthy balance sheet, suggesting a recovery from prior financial challenges. If the company can successfully navigate the regulatory risks associated with the No Surprises Act and demonstrate sustainable cash flow generation, its niche in micro-hospitals could provide a platform for further, albeit high-risk, growth.
Is NUTX Stock Undervalued?
Unlock the full AI analysis for NUTX
Get the complete DVR score, risk analysis, and more
Unlock the full report
Create a free account to see the DVR score, risk flags, and AI analysis.
NUTX Price Targets & Strategy
12-Month Target
$150.00
Bull Case
$200.00
Bear Case
$50.00
Valuation Basis
Based on 30x forward P/E applied to estimated $5.00 FY26 EPS, reflecting Q4 miss and regulatory headwinds.
Entry Strategy
Dollar-cost average on dips below $90, or await greater clarity on No Surprises Act arbitration impact.
Exit Strategy
Take profit at $150-$200. Set a stop-loss order if the price falls below $75, indicating deteriorating sentiment or fundamentals.
Portfolio Allocation
5% for aggressive risk tolerance.
Price Targets & Strategy
Upgrade to Premium for price targets and entry/exit strategies
Is NUTX Financially Healthy?
Valuation
P/E Ratio
9.89
Forward P/E
30.00
Profitability
Net Margin
10.76%
Return on Equity
42.08%
Revenue Growth
82.40%
EPS
$12.01
Balance Sheet
Current Ratio
3.41
Quick Ratio
3.39
Debt/Equity
0.70
Total Debt
$43.50M
Cash Flow
Operating Cash Flow
$248.10M
EBITDA
$259.60M
Other
Beta (Volatility)
0.03
Does NUTX Have a Competitive Moat?
Sign in to unlockMoat Rating
⚪ None
Moat Trend
Eroding
The company lacks a durable economic moat. Its reliance on arbitration as a revenue strategy is currently under regulatory threat, making its business model highly susceptible to external changes. There are no clear indications of network effects, switching costs, strong brand power, or proprietary technology creating a sustainable advantage.
Moat Erosion Risks
- •Adverse changes to healthcare legislation and regulatory environment, particularly regarding arbitration.
- •Increased competition in the micro-hospital and emergency care sector.
- •Inability to diversify revenue streams away from regulatory-sensitive models.
NUTX Competitive Moat Analysis
Sign up to see competitive advantages
NUTX Market Intelligence
Sentiment & Insider Activity
Social Sentiment
Neutral (no specific data provided)
Institutional Sentiment
Mixed; recent institutional stake (Pertento Partners) is positive, but analyst sentiment has seen a target cut (Maxim Group) and a strong-buy to hold downgrade (Wall Street Zen).
Insider Activity (Form 4)
President Warren Hosseinion bought 252 shares ($23,706) on March 19, 2026.
Options Flow
Normal options activity (no specific unusual activity provided)
Earnings Intelligence
Next Earnings
Q1 2026 (Expected May 2026, date TBD)
Surprise Probability
Medium
Historical Earnings Pattern
Unpredictable (historical reaction patterns not provided in research)
Key Metrics to Watch
Competitive Position
Top Competitor
No specific best-in-class competitor provided in research.
Market Share Trend
Stable/Unknown (no data provided)
Valuation vs Peers
Unable to compare without peer valuation data or sector medians.
Competitive Advantages
- •Claimed 80%+ win rate in arbitration (though sustainability is questioned)
- •Focus on micro-hospital and emergency care model
Market Intelligence
Get sentiment, earnings intel, and peer analysis with Premium
What Could Drive NUTX Stock Higher?
Near-Term (0-6 months)
- •Q1 2026 Earnings (Expected May 2026)
- •Clarity or favorable resolution regarding No Surprises Act arbitration rules
Medium-Term (6-18 months)
- •Continued expansion of micro-hospital network in new geographies
- •Announcements of new strategic partnerships to diversify revenue streams
Long-Term (18+ months)
- •Establishment of a durable competitive advantage beyond arbitration dependency
- •Transition towards more value-based care models for long-term sustainability
Catalysts & Growth Drivers
Upgrade to Premium to see catalysts
What's the Bull Case for NUTX?
- ✓
Positive and growing Free Cash Flow (FCF) reported in upcoming earnings.
- ✓
Clear and favorable resolution or guidance from regulators on the No Surprises Act impact.
- ✓
Diversification of revenue sources beyond arbitration.
Bull Case Analysis
See what could go right with Premium
Competing with NUTX
See how Nutex Health Inc compares to related companies
| Company | Market Cap | DVR Score | P/E | Revenue | Profit Margin | Rev Growth | |
|---|---|---|---|---|---|---|---|
Nutex Health Inc NUTX | $618.9M | 2.0 | 9.9 | $875.3M | 10.8% | 82.4% | |
AbbVie Inc ABBV | $403.8B | 0.1 | 171.8 | — | — | — | Compare → |
Johnson & Johnson JNJ | — | 1.0 | — | — | — | — | Compare → |
Eli Lilly and Co LLY | $965.0B | 0.5 | 52.6 | — | — | — | Compare → |
Pfizer Inc PFE | $150.6B | 0.2 | 19.4 | $62.6B | 12.4% | -1.6% | Compare → |
UnitedHealth Group Inc UNH | $276.2B | 0.3 | 22.9 | $113.7B | 2.7% | 1181.0% | Compare → |
📊 Explore More Stock Analysis
Get comprehensive Deep Value Reports for thousands of stocks. Research risk, financial health, and investment potential with our AI-powered analysis.
FAQ
What is the DVR Score for Nutex Health Inc (NUTX)?
As of March 25, 2026, Nutex Health Inc has a DVR Score of 2.0 out of 10, placing it in the "Risk Trap" category. This score is generated by our AI-powered deep value analysis framework that evaluates growth potential, financial health, competitive moat, and risk factors.
What is the market capitalization of Nutex Health Inc?
Nutex Health Inc's market capitalization is approximately $618.9M. The company operates in the Healthcare sector within the Medical Care Facilities industry.
What ticker symbol does Nutex Health Inc use?
NUTX is the ticker symbol for Nutex Health Inc. The company trades on the NCM.
What is the risk level for NUTX stock?
Our analysis rates Nutex Health Inc's overall risk as Aggressive. This assessment considers execution risk, market risk, financial risk, competitive risk, and regulatory risk. For a full breakdown, see the risk analysis section above.
What is the P/E ratio of NUTX?
Nutex Health Inc currently has a price-to-earnings (P/E) ratio of 9.9. This is below the market average, which could indicate the stock is undervalued or facing headwinds.
Is Nutex Health Inc's revenue growing?
Nutex Health Inc has reported revenue growth of 82.4%. The company is showing strong top-line momentum.
Is NUTX stock profitable?
Nutex Health Inc has a profit margin of 10.8%. The company is profitable but margins are modest.
How often is the NUTX DVR analysis updated?
Our AI-powered analysis of Nutex Health Inc is refreshed regularly to incorporate the latest financial data, market conditions, and news. The most recent update was on March 25, 2026.
Important Disclaimer – Not Financial Advice
Deep Value Reports is an independent research platform for educational and informational purposes only. We are not financial advisors, investment advisors, or licensed professionals. The analysis, scores, and information provided on this page for NUTX (Nutex Health Inc) should not be construed as personalized investment advice, a recommendation to buy or sell any security, or an offer to provide investment advisory services.
All investments involve risk, including the potential loss of principal. Past performance does not guarantee future results. Always conduct your own research, consider your financial situation, and consult with a qualified financial advisor before making any investment decisions.